PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes

被引:7637
作者
Mootha, VK
Lindgren, CM
Eriksson, KF
Subramanian, A
Sihag, S
Lehar, J
Puigserver, P
Carlsson, E
Ridderstråle, M
Laurila, E
Houstis, N
Daly, MJ
Patterson, N
Mesirov, JP
Golub, TR
Tamayo, P
Spiegelman, B
Lander, ES
Hirschhorn, JN
Altshuler, D
Groop, LC
机构
[1] MIT, Whitehead Inst, Ctr Genome Res, Cambridge, MA 02139 USA
[2] Harvard Med Sch, Dept Med, Boston, MA USA
[3] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA
[4] Lund Univ, Dept Endocrinol, Wallenberg Lab, Univ Hosp MAS, S-20502 Malmo, Sweden
[5] Harvard Med Sch, Dana Farber Canc Inst, Boston, MA USA
[6] MIT, Dept Biol, Cambridge, MA USA
[7] Harvard Med Sch, Dept Genet, Boston, MA USA
[8] Childrens Hosp, Dept Pediat, Boston, MA 02115 USA
[9] Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA
[10] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA
[11] Massachusetts Gen Hosp, Diabet Unit, Boston, MA 02114 USA
基金
英国惠康基金;
关键词
D O I
10.1038/ng1180
中图分类号
Q3 [遗传学];
学科分类号
071007 [遗传学]; 090102 [作物遗传育种];
摘要
DNA microarrays can be used to identify gene expression changes characteristic of human disease. This is challenging, however, when relevant differences are subtle at the level of individual genes. We introduce an analytical strategy, Gene Set Enrichment Analysis, designed to detect modest but coordinate changes in the expression of groups of functionally related genes. Using this approach, we identify a set of genes involved in oxidative phosphorylation whose expression is coordinately decreased in human diabetic muscle. Expression of these genes is high at sites of insulin-mediated glucose disposal, activated by PGC-1alpha and correlated with total-body aerobic capacity. Our results associate this gene set with clinically important variation in human metabolism and illustrate the value of pathway relationships in the analysis of genomic profiling experiments.
引用
收藏
页码:267 / 273
页数:7
相关论文
共 33 条
[1]
BJOMTORP P, 1967, DIABETOLOGIA, V3, P346
[2]
BROWN GC, 1992, BIOCHEM J, V284, P1
[3]
MAPPFinder: using Gene Ontology and GenMAPP to create a global gene-expression profile from microarray data [J].
Doniger, SW ;
Salomonis, N ;
Dahlquist, KD ;
Vranizan, K ;
Lawlor, SC ;
Conklin, BR .
GENOME BIOLOGY, 2003, 4 (01)
[4]
Global functional profiling of gene expression [J].
Draghici, S ;
Khatri, P ;
Martins, RP ;
Ostermeier, GC ;
Krawetz, SA .
GENOMICS, 2003, 81 (02) :98-104
[5]
Cluster analysis and display of genome-wide expression patterns [J].
Eisen, MB ;
Spellman, PT ;
Brown, PO ;
Botstein, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (25) :14863-14868
[6]
Mutation analysis of peroxisome proliferator-activated receptor-γ coactivator-1 (PGC-1) and relationships of identified amino acid polymorphisms to Type II diabetes mellitus [J].
Ek, J ;
Andersen, G ;
Urhammer, SA ;
Gæde, PH ;
Drivsholm, T ;
Borch-Johnsen, K ;
Hansen, T ;
Pedersen, O .
DIABETOLOGIA, 2001, 44 (12) :2220-2226
[7]
INCREASED SKELETAL-MUSCLE CAPILLARY DENSITY PRECEDES DIABETES DEVELOPMENT IN MEN WITH IMPAIRED GLUCOSE-TOLERANCE - A 15-YEAR FOLLOW-UP [J].
ERIKSSON, KF ;
SALTIN, B ;
LINDGARDE, F .
DIABETES, 1994, 43 (06) :805-808
[8]
IMPAIRED GLUCOSE-TOLERANCE IN A MIDDLE-AGED MALE URBAN-POPULATION - A NEW APPROACH FOR IDENTIFYING HIGH-RISK CASES [J].
ERIKSSON, KF ;
LINDGARDE, F .
DIABETOLOGIA, 1990, 33 (09) :526-531
[9]
Mechanisms of disease: Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. [J].
Fajans, SS ;
Bell, GI ;
Polonsky, KS .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (13) :971-980
[10]
FLOREZ JC, IN PRESS ANN REV GEN